Lower Hospitalization and Total Healthcare Costs Among Patients with Heart Failure When Treated with Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker: A Retrospective Study of Managed Care Claims
2019 ◽
Vol 8
(9)
◽
2009 ◽
Vol 15
(4)
◽
pp. 170-175
◽
2009 ◽
Vol 120
(16)
◽
pp. 1577-1584
◽